Key Highlights

  • Getty Images is trading 29.03% higher at about $0.02 during its prepackaged Chapter 11 case, and the plan would cancel all roughly 421 million existing shares.
  • Karyopharm is trading 27.46% higher at $0.61, with its lender forbearance period running to 11:59 p.m. Eastern time on November 1, 2026.
  • Freight Technologies is trading 13.19% lower at $1.01 and is down about 98.8% this year.
  • Xiao-I short interest was 307,987 shares for the October 15 settlement date, about 54.5% of shares outstanding (calculated).
  • CERo Therapeutics Holdings is unchanged with the quote below one cent while a 30-day go-shop runs on the sale of its operating subsidiary.

Which Stocks Are Under Financial or Restructuring Pressure on October 28?

Five stocks tied to bankruptcy, debt forbearance, a pending asset sale, repeated reverse splits or going-concern doubt are active on Wednesday, October 28, 2026. Getty Images (OTC:GETY) is trading 29.03% higher at about $0.02 during its prepackaged Chapter 11 case, and Karyopharm (NASDAQ:KPTI) is trading 27.46% higher at $0.61 as a lender forbearance period runs to November 1. Freight Technologies (NASDAQ:FRGT) is trading 13.19% lower at $1.01, Xiao-I (NASDAQ:AIXI) is trading 1.02% higher at $2.98, and CERo Therapeutics Holdings (OTC:CERO) is unchanged with the quote below one cent.

The ranking follows the size of each move, measured as the absolute percentage change in the share price today, so a decline counts by its size and not its direction. No company release dated October 28 accompanies any of the five moves, and each section says what the dated filings show instead.

1. Getty Images: Why Are Shares Jumping 29.03% During Chapter 11?

Shares are trading 29.03% higher at about $0.02, a price rounded to the cent after a $0.02 close on October 20. Seven Getty entities filed prepackaged Chapter 11 petitions in Delaware on October 21, 2026, and the plan would cancel all roughly 421 million existing shares with no distribution to holders. At that share count the equity is valued near $8.4 million (calculated).

The plan eliminates more than $500 million of about $1.46 billion in funded debt, and affiliates of the Getty family and Koch Equity Development would take 100% of the reorganized company. A roughly $3.7 billion merger with Shutterstock (NYSE:SSTK) collapsed, and the NYSE delisted the stock on October 12, so it trades over the counter, where one-cent steps create large percentage swings.

2. Karyopharm: Can $65.1 Million Cover $69.5 Million in Scheduled Debt Payments?

Shares are trading 27.46% higher at $0.61 after closing at $0.4821 on Monday, October 26, following a 6.84% decline that day. Karyopharm is a commercial-stage drugmaker whose main marketed product is the cancer medicine XPOVIO, and about 22.68 million shares put the equity near $13.8 million (calculated).

A forbearance agreement signed on September 10, 2026 was extended on October 22 to 11:59 p.m. Eastern time on November 1. Cash and equivalents were $55.0 million at June 30 plus $10.1 million of investments, against $69.5 million of scheduled debt payments through June 30, 2027, and the quarterly report states substantial doubt about continuing as a going concern. Short interest was 7,266,973 shares for the October 15 settlement date, about 32% of shares outstanding (calculated).

3. Freight Technologies: Why Are Shares Down 13.19% After a Capital Clean-Up?

Shares are trading 13.19% lower at $1.01 against a prior close of $1.16, nine days after the company, which operates under the Fr8Tech brand, said it had retired legacy preferred shares and cleared its 2023 warrants. Exchanging preferred stock for rights to ordinary shares can add to the supply of common shares. The company runs a cloud-based freight platform for cross-border trade between the United States and Mexico.

Trailing 12-month revenue was $13.06 million against a net loss of $7.90 million, with cash of $346,718 against $3.44 million of total debt. The stock is down about 98.8% this year after repeated reverse splits. Latest available short interest was 174,695 shares, or 31.22% of the roughly 559,517 shares outstanding.

4. Xiao-I: What Does a 54.5% Short Position Mean for a Tiny Share Base?

Shares are trading 1.02% higher at $2.98 after closing at $2.96 on Friday, October 23, following a 19.35% jump that day. Xiao-I is a China-based artificial intelligence company founded in 2001 that makes virtual assistants, chatbots and customer-service software, and its American depositary shares trade on Nasdaq. At 565,210 shares outstanding the market value is about $1.7 million (calculated).

Short interest was 307,987 shares for the October 15, 2026 settlement date, up from 43,575 on September 30. A Nasdaq deficiency notice arrived on August 20, a 1-for-20 reverse split took effect on May 11, and cash of $3.45 million sits against total debt of $53.51 million. The company also intends to appeal first-instance rulings in its patent case against Apple (NASDAQ:AAPL).

5. CERo Therapeutics Holdings: Why Is an Unchanged Penny Stock Among the Most Active?

Shares are unchanged at 0.00% with the quote below one cent, and no company release dated today explains the heavy trading. CERo is an early-stage immunotherapy company in South San Francisco developing engineered T cell therapies for cancer, and its main candidate, CER-1236, is in a Phase 1/1b trial in acute myeloid leukemia. At the August 19 price the market value is about $0.77 million (calculated).

Under an October 6, 2026 agreement, the company sells its operating subsidiary to SRX Global (NYSEAMERICAN:SRXH) for SRX stock valued at $1.0 million, cancellation of a senior secured note with $8,249,643.77 of principal and assumption of about $1.562 million of liabilities. Cash was $937,512 at June 30 against a working capital deficit of about $30.9 million, and the statements flag going-concern doubt.

Financial Pressure Compared: Move Gaps, Equity Values and Short Positions

Getty's 29.03% gain is 1.57 percentage points above Karyopharm's 27.46% (calculated), and it sits 42.22 points above Freight Technologies' 13.19% decline (calculated). Xiao-I's 1.02% rise is 28.01 points below Getty's move (calculated). Karyopharm's equity of about $13.8 million is $5.4 million above Getty's $8.4 million (calculated), yet Getty carries about $1.46 billion of funded debt, roughly 174 times its equity value (calculated). Xiao-I's $53.51 million of debt is about 31 times its $1.7 million market value (calculated).

On short interest, Xiao-I's 54.5% of shares outstanding is 22.5 points above Karyopharm's roughly 32% and 23.28 points above Freight Technologies' 31.22% (calculated). All three are shares-outstanding measures, but Freight Technologies' reading carries no stated date while the other two are for October 15. Karyopharm's $65.1 million of cash and investments falls $4.4 million short of its $69.5 million of scheduled payments (calculated).

What to Watch Next: November 1 Forbearance Deadline, Go-Shop End and the December 14 Getty Hearing

Karyopharm's forbearance period ends at 11:59 p.m. Eastern time on November 1, 2026 unless extended again, and its third-quarter results are estimated for around November 6. CERo's go-shop ends around November 5 (calculated). Xiao-I's next short-interest settlement date is October 30, with data expected on November 10. For Getty, the voting deadline is November 30, the voting report is due December 7, the combined plan hearing is set for December 14 and the projected effective date is December 31.